Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 July 1998 | Volume 129 Issue 2 | Pages 89-93
Background: A mutation in the prothrombin gene (G
Objective: To determine whether the prothrombin A20210 allele is independently associated with the occurrence of venous thrombosis.
Design: Case-control study.
Setting: Two thrombosis centers in southern Italy.
Patients: 281 consecutive patients with venous thrombosis confirmed by objective tests and 850 controls.
Measurements: Medical history was collected on standardized questionnaires. The presence of prothrombin G
Results: In 150 controls, increased prothrombin activity (P < 0.001) was associated with the prothrombin A20210 allele. This allele was more frequent in patients than in controls (8.01% compared with 2.29%; P < 0.001) and was associated with an increased risk for thrombosis (odds ratio, 3.88 [95% CI, 2.23 to 6.74]). The increased prevalence of this allele was independent of the presence of the factor V Leiden mutation. After adjustment for sex, age, arterial thrombosis, and factor V Leiden mutation, the risk was still significantly elevated (odds ratio, 3.13 [CI, 1.89 to 5.21]). Moreover, the overall prevalence of inherited coagulation abnormalities was significantly higher in patients with thrombosis of the lower extremities than in patients with thrombosis of the upper extremities (odds ratio, 3.77 [CI, 1.10 to 12.93]). Fourteen patients carried both the prothrombin G
Conclusions: The prothrombin A20210 allele is independently associated with the occurrence of venous thrombosis, particularly in patients with a history of thrombosis of the lower extremities.
Author and Article Information
From IRCCS, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; Ospedale A. Cardarelli, Napoli, Italy; and Universita di Palermo, Palermo, Italy.
ARTICLE
Increased Risk for Venous Thrombosis in Carriers of the Prothrombin G
A20210 Gene Variant
A20210) has been associated with higher plasma prothrombin levels and an increased tendency for venous thrombosis.
A20210 and factor V Leiden mutations was determined by polymerase chain reaction. The presence of anticoagulant factors and prothrombin activity was determined by tests of function.
A20210 and factor V Leiden mutations.
![]()
Requests for Reprints: Maurizio Margaglione, MD, Unita di Aterosclerosi e Trombosi, IRCCS, Casa Sollievo della Sofferenza, viale Cappuccini, San Giovanni Rotondo (FG) 71013, Italy.
Current Author Addresses: Drs. Margaglione, Giuliani, and Grandone and Mrs. D'Andrea, Mr. Cappucci, and Mr. Vecchione: Unita di Aterosclerosi e Trombosi, IRCCS, Casa Sollievo della Sofferenza, viale Cappuccini, San Giovanni Rotondo (FG) 71013, Italy.
This article has been cited by other articles:
![]() |
D. Colaizzo, L. Amitrano, L. Iannaccone, P. Vergura, F. Cappucci, E. Grandone, M. A. Guardascione, and M. Margaglione Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings J. Med. Genet., June 1, 2007; 44(6): 412 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Coppens, M. H. van de Poel, I. Bank, K. Hamulyak, J. van der Meer, N. J. Veeger, M. H. Prins, H. R. Buller, and S. Middeldorp A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation Blood, October 15, 2006; 108(8): 2604 - 2607. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bosler, J. Mattson, and D. Crisan Phenotypic Heterogeneity in Patients with Homozygous Prothrombin 20210AA Genotype: A Paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology J. Mol. Diagn., September 1, 2006; 8(4): 420 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Feinbloom and K. A. Bauer Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2043 - 2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Saxena, M. Ranalli, N. Khan, C. Blanchong, and S. B. Kahwash Fatal Stroke in a Child with Severe Iron Deficiency Anemia and Multiple Hereditary Risk Factors for Thrombosis Clinical Pediatrics, March 1, 2005; 44(2): 175 - 180. [PDF] |
||||
![]() |
M. Sachchithananthan, S. J. Stasinopoulos, J. Wilusz, and R. L. Medcalf The relationship between the prothrombin upstream sequence element and the G20210A polymorphism: the influence of a competitive environment for mRNA 3'-end formation Nucleic Acids Res., February 17, 2005; 33(3): 1010 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kearon Long-Term Management of Patients After Venous Thromboembolism Circulation, August 31, 2004; 110(9_suppl_1): I-10 - I-18. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Grandone, D. Colaizzo, P. Vergura, F. Cappucci, G. Vecchione, A. Lo Bue, E. Cittadini, and M. Margaglione Age and homocysteine plasma levels are risk factors for thrombotic complications after ovarian stimulation Hum. Reprod., August 1, 2004; 19(8): 1796 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Juul, A. Tybjaerg-Hansen, P. Schnohr, and B. G. Nordestgaard Factor V Leiden and the Risk for Venous Thromboembolism in the Adult Danish Population Ann Intern Med, March 2, 2004; 140(5): 330 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. von Ahsen and M. Oellerich The intronic prothrombin 19911A>G polymorphism influences splicing efficiency and modulates effects of the 20210G>A polymorphism on mRNA amount and expression in a stable reporter gene assay system Blood, January 15, 2004; 103(2): 586 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. McBane II Genetically Determined Procoagulant States and Heparin Use Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2003; 7(4): 427 - 442. [Abstract] [PDF] |
||||
![]() |
M. H. Eckman, J. K. Erban, S. K. Singh, and G. S. Kao Screening for the Risk for Bleeding or Thrombosis Ann Intern Med, February 4, 2003; 138(3): W-15 - W-24. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R Deitcher and M. P. Gomes Hypercoagulable state testing and malignancy screening following venous thromboembolic events Vascular Medicine, February 1, 2003; 8(1): 33 - 46. [Abstract] [PDF] |
||||
![]() |
H. Austin, M. I. Chimowitz, H. A. Hill, S. Chaturvedi, L. R. Wechsler, R. J. Wityk, E. Walz, J. L. Wilterdink, B. Coull, C. A. Sila, et al. Cryptogenic Stroke in Relation to Genetic Variation in Clotting Factors and Other Genetic Polymorphisms Among Young Men and Women * Editorial Comment Stroke, December 1, 2002; 33(12): 2762 - 2768. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Dalen Pulmonary Embolism: What Have We Learned Since Virchow?: Natural History, Pathophysiology, and Diagnosis Chest, October 1, 2002; 122(4): 1440 - 1456. [Full Text] [PDF] |
||||
![]() |
C. Legnani, G. Palareti, G. Guazzaloca, B. Cosmi, B. Lunghi, F. Bernardi, and S. Coccheri Venous thromboembolism in young women. Role of thrombophilic mutations and oral contraceptive use Eur. Heart J., June 2, 2002; 23(12): 984 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mira, J. Todoli, R. Alonso, M. L. Mico, A. Vaya, F. Ferrando, A. Estelles, P. Villa, and J. Aznar Factor V Leiden and Prothrombin G20210A in Relation to Arterial and/or Vein Rethrombosis: Two Cases Clinical and Applied Thrombosis/Hemostasis, July 1, 2001; 7(3): 234 - 237. [Abstract] [PDF] |
||||
![]() |
D. G. Federman and R. S. Kirsner An Update on Hypercoagulable Disorders Arch Intern Med, April 23, 2001; 161(8): 1051 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Seligsohn and A. Lubetsky Genetic Susceptibility to Venous Thrombosis N. Engl. J. Med., April 19, 2001; 344(16): 1222 - 1231. [Full Text] [PDF] |
||||
![]() |
P. Simioni, P. Prandoni, A. W. A. Lensing, D. Manfrin, D. Tormene, S. Gavasso, B. Girolami, C. Sardella, M. Prins, and A. Girolami Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis Blood, November 15, 2000; 96(10): 3329 - 3333. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Margaglione, V. Brancaccio, D. De Lucia, I. Martinelli, A. Ciampa, E. Grandone, and G. Di Minno Inherited Thrombophilic Risk Factors and Venous Thromboembolism : Distinct Role in Peripheral Deep Venous Thrombosis and Pulmonary Embolism Chest, November 1, 2000; 118(5): 1405 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Gonzalez Ordonez, J. M. Fernandez Carreira, M. V. Alvarez, L. Martin Sanchez, J. M. Medina Rodriguez, and E. Coto Garcia A High Factor II/Factor X Functional Ratio Is Not a Useful Predictor of the FII G20210A Gene Mutation in Thromboembolic Patients Undergoing Oral Anticoagulant Treatment Clin. Chem., June 1, 2000; 46(6): 886 - 887. [Full Text] [PDF] |
||||
![]() |
A. Nguyen State-of-the-Art Review : Review and Management of Patients With the Prothrombin G20210A Polymorphism Clinical and Applied Thrombosis/Hemostasis, April 1, 2000; 6(2): 94 - 99. [Abstract] [PDF] |
||||
![]() |
A. Irish Renal allograft thrombosis: can thrombophilia explain the inexplicable? Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2297 - 2303. [Full Text] [PDF] |
||||
![]() |
V. De Stefano, I. Martinelli, P. M. Mannucci, K. Paciaroni, P. Chiusolo, I. Casorelli, E. Rossi, and G. Leone The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation N. Engl. J. Med., September 9, 1999; 341(11): 801 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Meinardi, P. M. Pelsma, H. Koning, J. van der Meer, and K. Hamulyak Double-Homozygosity for Factor V Leiden and the Prothrombin Gene G20210A Variant in a Young Patient With Idiopathic Venous Thrombosis Blood, September 1, 1999; 94(5): 1828 - 1829. [Full Text] [PDF] |
||||
![]() |
M. Margaglione, G. D'Andrea, N. Giuliani, V. Brancaccio, D. De Lucia, E. Grandone, V. De Stefano, P. A. Tonali, and G. Di Minno Inherited Prothrombotic Conditions and Premature Ischemic Stroke : Sex Difference in the Association With Factor V Leiden Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1751 - 1756. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Rosenberg and W. C. Aird Vascular-Bed-Specific Hemostasis and Hypercoagulable States N. Engl. J. Med., May 20, 1999; 340(20): 1555 - 1564. [Full Text] [PDF] |
||||